Biomarkers for chronic fatigue

[1]  F. Penedo,et al.  Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome , 2012, Brain, Behavior, and Immunity.

[2]  S. Ancoli-Israel,et al.  Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy , 2012, Brain, Behavior, and Immunity.

[3]  M. Arroyo-Morales,et al.  Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors. , 2012, Breast.

[4]  Myung Ah Lee,et al.  The relationship between interleukin-6, tumor necrosis factor-α, and fatigue in terminally ill cancer patients , 2012, Palliative medicine.

[5]  W. Malarkey,et al.  Fatigue and herpesvirus latency in women newly diagnosed with breast cancer , 2012, Brain, Behavior, and Immunity.

[6]  A. Light,et al.  Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients With Chronic Fatigue Syndrome, Patients With Multiple Sclerosis, and Healthy Controls , 2012, Psychosomatic medicine.

[7]  A. Light,et al.  Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome , 2012, Journal of internal medicine.

[8]  D. Radice,et al.  Breast Cancer Management , 2012, PharmacoEconomics.

[9]  N. Klimas,et al.  Chronic Fatigue Syndrome , 2012, Drugs.

[10]  Anthony J. Cleare,et al.  Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome , 2012, Nature Reviews Endocrinology.

[11]  C. Bernstein,et al.  Fatigue and Quality of Sleep in Patients with Immune-Mediated Inflammatory Disease , 2011, The Journal of Rheumatology. Supplement.

[12]  H. Rafatpanah,et al.  Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? , 2011, Lupus.

[13]  S. Fosså,et al.  Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway , 2011, Brain, Behavior, and Immunity.

[14]  M. Irwin,et al.  Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Lix,et al.  A population‐based study of fatigue and sleep difficulties in inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[16]  Ingrid J Orre,et al.  Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. , 2011, Journal of psychosomatic research.

[17]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.

[18]  B. Nordestgaard,et al.  Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer , 2011, Critical reviews in clinical laboratory sciences.

[19]  T. Bernklev,et al.  Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls , 2011, Inflammatory bowel diseases.

[20]  N. Klimas,et al.  Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis , 2011, Journal of Translational Medicine.

[21]  L. Cannon-Albright,et al.  Evidence for a heritable predisposition to Chronic Fatigue Syndrome , 2011, BMC neurology.

[22]  P. Kellam,et al.  Assessment of a 44 Gene Classifier for the Evaluation of Chronic Fatigue Syndrome from Peripheral Blood Mononuclear Cell Gene Expression , 2011, PloS one.

[23]  Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome. , 2011, Clinical and experimental rheumatology.

[24]  Richard D. Smith,et al.  Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome , 2011, PloS one.

[25]  C. Otte,et al.  Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  Gordon Broderick,et al.  A pilot study of immune network remodeling under challenge in Gulf War Illness , 2011, Brain, Behavior, and Immunity.

[27]  M. Irwin,et al.  Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue , 2011, Brain, Behavior, and Immunity.

[28]  Dave Singh,et al.  Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD , 2011, Respiratory research.

[29]  T. Ernst,et al.  Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals , 2011, Journal of NeuroVirology.

[30]  M. Antoni,et al.  Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome , 2010, Behavioral and Brain Functions.

[31]  Gordon Broderick,et al.  A formal analysis of cytokine networks in Chronic Fatigue Syndrome , 2010, Brain, Behavior, and Immunity.

[32]  Jin-Mann S. Lin,et al.  Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. , 2010, Metabolism: clinical and experimental.

[33]  R. Chervin,et al.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. , 2010, Sleep.

[34]  C. Cleeland,et al.  Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy , 2010, Brain, Behavior, and Immunity.

[35]  A. Light,et al.  Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. , 2010, Psychophysiology.

[36]  S. Mathew,et al.  Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder , 2010, NMR in biomedicine.

[37]  G. Bleijenberg,et al.  Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. , 2010, Rheumatology.

[38]  Kevin Maher,et al.  Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26 , 2010, PloS one.

[39]  U. Nater,et al.  Neuroendocrine and Immune Contributors to Fatigue , 2010, PM & R : the journal of injury, function, and rehabilitation.

[40]  A. Børresen-Dale,et al.  The Genetics and Epigenetics of Fatigue , 2010, PM & R : the journal of injury, function, and rehabilitation.

[41]  B. Andersen,et al.  The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. , 2010, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[42]  N. Nishimoto,et al.  Cytokine Networks in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[43]  G. Treharne,et al.  A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. , 2010, Rheumatology.

[44]  M. Nimmo,et al.  Plasma IL‐6, its soluble receptors and F2‐isoprostanes at rest and during exercise in chronic fatigue syndrome , 2009, Scandinavian journal of medicine & science in sports.

[45]  E. Stevenson,et al.  The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response. , 2010, Exercise immunology review.

[46]  M. Fujita,et al.  Fluctuation of serum vitamin E (α-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome , 2010, Heart and Vessels.

[47]  Mary Ann Fletcher,et al.  Plasma cytokines in women with chronic fatigue syndrome , 2009, Journal of Translational Medicine.

[48]  R. Omdal,et al.  Fatigue in primary Sjögren’s syndrome – A link to sickness behaviour in animals? , 2009, Brain, Behavior, and Immunity.

[49]  N. Klimas,et al.  Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. , 2009, Clinical science.

[50]  A. Light,et al.  Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. , 2009, The journal of pain : official journal of the American Pain Society.

[51]  P. Gibson,et al.  Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[52]  P. Ganz,et al.  Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer , 2009, Clinical Cancer Research.

[53]  S. Delliaux,et al.  Chronic fatigue syndrome combines increased exercise‐induced oxidative stress and reduced cytokine and Hsp responses , 2009, Journal of internal medicine.

[54]  Ingrid J Orre,et al.  Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue , 2009, Brain, Behavior, and Immunity.

[55]  S. Wessely,et al.  Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? , 2009, Psychological Medicine.

[56]  P. Sullivan,et al.  Gene Expression in Peripheral Blood Leukocytes in Monozygotic Twins Discordant for Chronic Fatigue: No Evidence of a Biomarker , 2009, PloS one.

[57]  Jin-Mann S. Lin,et al.  Association of peripheral inflammatory markers with chronic fatigue in a population-based sample , 2009, Brain, Behavior, and Immunity.

[58]  M. Boncler,et al.  Regulation of cell function by isoforms of C-reactive protein: a comparative analysis. , 2009, Acta Biochimica Polonica.

[59]  G. Freund,et al.  Behavioral recovery from acute hypoxia is reliant on leptin , 2009, Brain, Behavior, and Immunity.

[60]  R. Breitling.  Robust signaling networks of the adipose secretome , 2009, Trends in Endocrinology & Metabolism.

[61]  Amos Ben-Zvi,et al.  Model-Based Therapeutic Correction of Hypothalamic-Pituitary-Adrenal Axis Dysfunction , 2009, PLoS Comput. Biol..

[62]  S. Myhill,et al.  Chronic fatigue syndrome and mitochondrial dysfunction. , 2009, International journal of clinical and experimental medicine.

[63]  Suzanne D Vernon,et al.  Impaired immune function in Gulf War Illness , 2009, BMC Medical Genomics.

[64]  Gordon Broderick,et al.  Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. , 2008, Genomics.

[65]  Gordon Broderick,et al.  Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood , 2008, Behavioral and Brain Functions.

[66]  W. Bardwell,et al.  Predictors of fatigue in obstructive sleep apnea , 2008, Sleep and Breathing.

[67]  Paul Kellam,et al.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.

[68]  G. Kennedy,et al.  Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. , 2008, Clinical science.

[69]  M. Irwin,et al.  Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: Implications for fatigue , 2008, Brain, Behavior, and Immunity.

[70]  M. Fletcher,et al.  The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. , 2008, Journal of applied biobehavioral research.

[71]  M. Maes,et al.  Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. , 2007, Neuro endocrinology letters.

[72]  J. Bower,et al.  Cancer-related fatigue: Links with inflammation in cancer patients and survivors , 2007, Brain, Behavior, and Immunity.

[73]  Kenneth H. Buetow,et al.  Identification of Key Processes Underlying Cancer Phenotypes Using Biologic Pathway Analysis , 2007, PloS one.

[74]  L. Natarajan,et al.  The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review , 2007, Brain, Behavior, and Immunity.

[75]  W. Reeves,et al.  Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome , 2007, Genes, brain, and behavior.

[76]  R. Craddock,et al.  Identifying illness parameters in fatiguing syndromes using classical projection methods. , 2006, Pharmacogenomics.

[77]  S. Gold,et al.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[78]  M. Fletcher,et al.  Chronic fatigue syndrome is associated with diminished intracellular perforin , 2005, Clinical and experimental immunology.

[79]  Daniel J Clauw,et al.  A chronic fatigue syndrome – related proteome in human cerebrospinal fluid , 2005, BMC neurology.

[80]  G. Marshall,et al.  Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer , 2005, Brain, Behavior, and Immunity.

[81]  Nicolas Rohleder,et al.  Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome , 2005, Psychoneuroendocrinology.

[82]  S. Levison,et al.  Interleukin-1 and the Interleukin-1 Type 1 Receptor are Essential for the Progressive Neurodegeneration that Ensues Subsequent to a Mild Hypoxic/Ischemic Injury , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  F. Weber,et al.  Cytokine mRNA expression in patients with multiple sclerosis and fatigue , 2004, Multiple sclerosis.

[84]  T. Lallukka,et al.  Working conditions and health behaviours among employed women and men: the Helsinki Health Study. , 2004, Preventive medicine.

[85]  Y. Iwakura,et al.  IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions , 2003, The Journal of experimental medicine.

[86]  David C Hoaglin,et al.  Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. , 2003, Archives of internal medicine.

[87]  H. Price,et al.  Biochemical markers for post-operative fatigue after major surgery , 2003, Brain Research Bulletin.

[88]  R. Dantzer.  Cytokine-Induced Sickness Behavior: Where Do We Stand? , 2001, Brain, Behavior, and Immunity.

[89]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[90]  A. Rademaker,et al.  A community-based study of chronic fatigue syndrome. , 1999, Archives of internal medicine.

[91]  S. Kaasa,et al.  Fatigue in the general Norwegian population: normative data and associations. , 1998, Journal of psychosomatic research.

[92]  J. Meer.  CHRONIC FATIGUE SYNDROME , 1997 .

[93]  H. Calkins,et al.  The relationship between neurally mediated hypotension and the chronic fatigue syndrome. , 1995, JAMA.

[94]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.